The N-terminal pro-Brain Natriuretic Peptide (NT-proBNP), established as the leading diagnostic marker for heart failure, has been described in recent years in numerous population-based study samples as a promising prognostic factor for CVD events [5–7]. The gene discussed is NPPB; the disease is heart failure.